SCHEMBL811795

SCHEMBL811795

CC1Cc2ccccc2N1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.55
HTR2A P28223 4/20 0.47
HTR2C P28335 4/20 0.47
HTR2B P41595 4/20 0.47
LMNA P02545 2/20 0.46
MEN1 O00255 1/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
ROCK1 Q13464 1/20 0.44
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
ADRA1A P35348 1/20 0.43
HRH1 P35367 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7733992 1.00 NOTUM (0.55) NOTUMHTR2AHTR2CHTR2BLMNA
SCHEMBL31672940 1.00 NOTUM (0.55) NOTUMHTR2AHTR2CHTR2BLMNA
SCHEMBL6890897 1.00 NOTUM (0.55) NOTUMHTR2AHTR2CHTR2BLMNA
Ammonia Solution, Strong SCHEMBL29093479 0.98 NOTUM (0.53) NOTUMHTR2AHTR2CHTR2BLMNA
Hydrochloric Acid SCHEMBL28861795 0.98 NOTUM (0.53) NOTUMHTR2AHTR2CHTR2BLMNA
SCHEMBL27711736 0.89 NOTUM (0.50) NOTUMHTR2AHTR2CHTR2BLMNA
Formamide SCHEMBL4376802 0.89 NOTUM (0.50) NOTUMHTR2AHTR2CHTR2BLMNA
SCHEMBL787596 0.79 NOTUM (0.43) NOTUMHTR2AHTR2CHTR2BLMNA
SCHEMBL21172724 0.79 NOTUM (0.43) NOTUMHTR2AHTR2CHTR2BLMNA
SCHEMBL21172504 0.79 NOTUM (0.43) NOTUMHTR2AHTR2CHTR2BLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 420 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116135840-A Synthesis method of chiral 2-substituted-3, 3' -dimethylindoline derivative 中国科学院大连化学物理研究所 2023-05-19 CN claimed
CN-113855682-A Pyrrole drug molecule with sterilization and disinfection effects and preparation method and application thereof 河南科技大学第一附属医院 2021-12-31 CN claimed
CN-111943134-A Room-temperature dehydrogenation reaction system of photocatalytic organic liquid hydrogen storage material and preparation method and application thereof 中国科学院理化技术研究所 2020-11-17 CN claimed
WO-2018020518-A1 SQUARAINE DYES AND APPLICATIONS THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2018-02-01 WO claimed
CN-106349146-A Novel synthesis method of photochromic material 潘忠宁 2017-01-25 CN claimed
CN-101144992-A Erasable image forming material and manufacturing method thereof TOSHIBA KK (JP) 2008-03-19 CN claimed
WO-2005089214-A2 A TEMPERATURE-SENSING DEVICE FOR DETERMINING THE LEVEL OF A FLUID HADALA ANTHONY J (US) 2005-09-29 WO claimed
JP-2042084-A None JP disclosed
WO-2025215582-A1 SUBSTITUTED PYRAZOLOPYRIDINE AND PYRAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE GT GAIN THERAPEUTICS SA (CH) 2025-10-16 WO disclosed
US-20250320184-A1 SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF SIRONAX LTD (KY) 2025-10-16 US disclosed
US-20240244952-A1 ORGANIC LIGHT-EMITTING DEVICE AND ORGANOMETALLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
WO-2024073622-A2 RADIOPHARMACEUTICAL COMPOSITIONS TARGETING EPHRIN TYPE-A RECEPTOR 2 AND USES THEREOF RAYZEBIO, INC. (US) 2024-04-04 WO disclosed
US-20230276696-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORP (US) 2023-08-31 US disclosed
US-4268438-A Cationic 1,3,4-thiadiazole dyestuffs BAYER AKTIENGESELLSCHAFT (DE) 1981-05-19 US disclosed
US-4252716-A BLUE SHADES BAYER AKTIENGESELLSCHAFT (DE) 1981-02-24 US disclosed
EP-0005251-B1 PROCESS FOR THE PREPARATION OF SULFINATES OF 4,4'-DIAMINOBENZHYDROL AND OF ITS SUBSTITUTED PRODUCTS, AND COPYING PAPER CONTAINING THESE COMPOUNDS BAYER AG (DE) 1981-01-07 EP disclosed
US-4211436-A Pressure-sensitive recording material BAYER AKTIENGESELLSCHAFT (DE) 1980-07-08 US disclosed
EP-0005475-A1 Process for the preparation of 4,4'-diaminobenzhydrol and its substitution products BAYER AG (DE) 1979-11-28 EP disclosed
EP-0005251-A2 Process for the preparation of sulfinates of 4,4'-diaminobenzhydrol and of its substituted products, and copying paper containing these compounds BAYER AG (DE) 1979-11-14 EP disclosed
US-4006127-A Cationic diazacyanine dyestuffs BAYER AKTIENGESELLSCHAFT (DT) 1977-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250320184-A1 SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF SARM1, SMN1; SMN2, ADRM1 NOTUM 4269/4885HTR2A 3893/4885HTR2C 4602/4885
US-20240244952-A1 ORGANIC LIGHT-EMITTING DEVICE AND ORGANOMETALLIC COMPOUND LEF1, OCIAD1, OXA1L NOTUM 1150/4885HTR2A 4652/4885HTR2C 4280/4885
US-20230276696-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, PORCN NOTUM 1392/4885HTR2A 3632/4885HTR2C 2716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.